A detailed history of Forte Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Forte Capital LLC holds 4,674 shares of ABT stock, worth $537,463. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,674
Previous 4,275 9.33%
Holding current value
$537,463
Previous $444,000 19.82%
% of portfolio
0.06%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$100.07 - $118.13 $39,927 - $47,133
399 Added 9.33%
4,674 $532,000
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $15,210 - $16,978
-151 Reduced 3.41%
4,275 $444,000
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $9,090 - $10,039
-83 Reduced 1.84%
4,426 $503,000
Q4 2023

Feb 06, 2024

SELL
$90.19 - $110.4 $61,689 - $75,513
-684 Reduced 13.17%
4,509 $496,000
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $192,496 - $225,828
-2,025 Reduced 28.05%
5,193 $570,000
Q3 2022

Oct 21, 2022

BUY
$96.76 - $112.03 $4,063 - $4,705
42 Added 0.59%
7,218 $698,000
Q4 2021

Jan 20, 2022

SELL
$115.53 - $141.46 $25,301 - $30,979
-219 Reduced 2.96%
7,176 $1.01 Million
Q2 2021

Jul 28, 2021

SELL
$105.79 - $124.53 $48,557 - $57,159
-459 Reduced 5.84%
7,395 $857,000
Q1 2021

Apr 22, 2021

BUY
$108.84 - $128.23 $140,403 - $165,416
1,290 Added 19.65%
7,854 $941,000
Q4 2020

Jan 19, 2021

BUY
$105.0 - $114.42 $14,280 - $15,561
136 Added 2.12%
6,564 $719,000
Q3 2020

Nov 03, 2020

SELL
$91.64 - $111.29 $2,565 - $3,116
-28 Reduced 0.43%
6,428 $700,000
Q2 2020

Jul 09, 2020

BUY
$76.57 - $98.0 $494,335 - $632,688
6,456 New
6,456 $590,000
Q1 2018

Apr 17, 2018

SELL
$56.27 - $63.62 $365,361 - $413,084
-6,493 Closed
0 $0
Q4 2017

Jan 22, 2018

BUY
$53.68 - $57.47 $17,714 - $18,965
330 Added 5.35%
6,493 $370,000
Q3 2017

Oct 11, 2017

BUY
$48.06 - $53.64 $296,193 - $330,583
6,163
6,163 $329,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Forte Capital LLC Portfolio

Follow Forte Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forte Capital LLC , based on Form 13F filings with the SEC.

News

Stay updated on Forte Capital LLC with notifications on news.